Changes in coagulation and fibrinolysis variables during use of two oral contraceptives containing the same dose of ethinyl estradiol and either gestodene or desogestrel.
Gevers Leuven
J A
JA
Gaubius Institute TNO, Leiden, The Netherlands.
Kluft
C
C
Dersjant-Roorda
M C
MC
Harthoorn-Lasthuizen
E J
EJ
Peters
F P
FP
Bernsen
M J
MJ
Helmerhorst
F M
FM
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects*; D002570:Ceruloplasmin / Q000378:metabolism; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology*; D017135:Desogestrel; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005167:Factor VII / Q000378:metabolism; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D009652:Norpregnenes / Q000494:pharmacology; D010455:Peptides / Q000378:metabolism; D045167:Progesterone Congeners / Q000494:pharmacology; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism; D019396:Tissue Polypeptide Antigen
D003277:Contraceptives, Oral, Combined; D009652:Norpregnenes; D010455:Peptides; D045167:Progesterone Congeners; D012738:Sex Hormone-Binding Globulin; D019396:Tissue Polypeptide Antigen; C033273:Gestodene; D004997:Ethinyl Estradiol; D017135:Desogestrel; D005167:Factor VII; D002570:Ceruloplasmin